A detailed history of United Capital Financial Advisers, LLC transactions in Pfizer Inc stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 264,783 shares of PFE stock, worth $7.08 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
264,783
Previous 283,586 6.63%
Holding current value
$7.08 Million
Previous $7.93 Million 3.43%
% of portfolio
0.04%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $520,843 - $590,226
-18,803 Reduced 6.63%
264,783 $7.66 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $382,815 - $448,588
-15,155 Reduced 5.07%
283,586 $7.93 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $3.54 Million - $4.06 Million
-136,599 Reduced 31.38%
298,741 $8.29 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $12.3 Million - $15.9 Million
-469,332 Reduced 51.88%
435,340 $12.5 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $2.45 Million - $2.86 Million
-76,311 Reduced 7.78%
904,672 $30 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $2.38 Million - $2.76 Million
65,979 Added 7.21%
980,983 $36 Million
Q1 2023

Aug 14, 2023

SELL
$39.39 - $51.28 $2.79 Million - $3.64 Million
-70,944 Reduced 7.23%
910,039 $37.1 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $904,433 - $1.18 Million
-22,961 Reduced 2.45%
915,004 $37.3 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $426,434 - $556,663
10,214 Added 1.1%
937,965 $48.1 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $281,858 - $344,078
6,441 Added 0.7%
927,751 $40.6 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $1.7 Million - $2.01 Million
36,461 Added 4.12%
921,310 $48.3 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $531,660 - $658,794
11,621 Added 1.33%
884,849 $45.8 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $17.8 Million - $26.4 Million
431,637 Added 97.75%
873,228 $51.6 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $478,575 - $614,771
12,193 Added 2.84%
441,591 $19 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $554,917 - $628,628
-15,453 Reduced 3.47%
429,398 $16.8 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $653,456 - $736,968
-19,512 Reduced 4.2%
444,851 $16.1 Million
Q4 2020

Feb 17, 2021

BUY
$33.47 - $42.56 $653,200 - $830,600
19,516 Added 4.39%
464,363 $17.1 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $223,107 - $261,755
7,027 Added 1.6%
444,847 $16.3 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $818,330 - $992,755
-27,169 Reduced 5.84%
437,820 $14.3 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $3.81 Million - $5.45 Million
-141,049 Reduced 23.27%
464,989 $15.2 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $2.27 Million - $2.58 Million
69,041 Added 12.86%
606,038 $23.7 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $15.6 Million - $20.2 Million
-478,679 Reduced 47.13%
536,997 $19.3 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $1.12 Million - $1.25 Million
30,191 Added 3.06%
1,015,676 $44 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $1.87 Million - $2.06 Million
-49,914 Reduced 4.82%
985,485 $41.9 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $214,239 - $244,256
5,569 Added 0.54%
1,035,399 $45.2 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $1.35 Million - $1.64 Million
39,272 Added 3.96%
1,029,830 $45.4 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $663,095 - $706,926
-20,106 Reduced 1.99%
990,558 $35.9 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $1.18 Million - $1.37 Million
37,016 Added 3.8%
1,010,664 $35.9 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $243,529 - $258,393
7,322 Added 0.76%
973,648 $35.4 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $137,113 - $151,045
4,423 Added 0.46%
966,326 $34.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
961,903
961,903 $32.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.